Women's Health Innovation Summit, Europe 2022

Women's Health Innovation Summit

Showcasing innovation, fuelling investment, and driving partnerships across Europe and Israel to improve the outcomes, access, and quality of healthcare for women.

Register now
Basel, Switzerland
26-27 April, 2022

Register to watch a FREE webinar on-demand on 'Advancing menstrual health equity through the power of data and storytelling!

WHI 2022 STEERING COMMITTEE


WHY ATTEND?

Building on the success of the Women’s Health Innovation Summit USA, we are delighted to announce we are coming to Europe to continue the acceleration of innovation and investment in women’s health and Femtech solutions!

Globally, the European women’s health market is one of the fastest growing, with new technologies, therapeutics, devices, platforms and approaches being developed to improve women’s’ access and quality of care.

Our summit will bring together the leaders & innovators from Europe and Israel, from big pharmaceutical and medical device companies, to start-ups, Femtech, VC’s and incubator funds, to drive successful partnerships, showcase leading disruptive solutions, and to fuel the growth of these businesses and the women’s health sector.

Join the leading industry network in women’s health; our 2-day summit is guaranteed to bring value to your business strategy, connections, and growth.

2022 Innovation Showcase

To kick-off our European summit, we’re showcasing the latest and best
innovations in women’s health across Europe and Israel.


15 innovative startups, selected by our prestigious Selection Committee
will take to the stage in a quick-fire round of presentations to highlight
a technology, device, service, or product that is driving the future of the
women’s health market.


If selected, startups will get the opportunity to present in front of 200+
potential investors and partners and be at the forefront of driving
solutions for unmet needs in all categories of women’s health.


All applications are stage agnostic and can relate to all solutions across
women’s health from ovarian cancer to fertility.

APPLY HERE

Deadline: 15th March 

Women's Health Series Past Attendees

2022 Partners

Platinum Partners

Gold Partners

Media Partner

AUDIENCE BREAKDOWN

5%
Non-profits/ Advocacy Groups
20%
Investor/Funding Groups
5%
Payors/ Providers/ Employers
35%
Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs
40%
Start Ups/ Femtech/ Entrepreneurs/ Innovation
5%
Service Providers

Non-profits/ Advocacy Groups

Investor/Funding Groups

Payors/ Providers/ Employers

Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs

Start Ups/ Femtech/ Entrepreneurs/ Innovation

Service Providers

2022 Speakers

 

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures
 

Andrea Zitna

Principal
Speedinvest

Andrea Zitna is the Principal at Speedinvest, focusing on early-stage health investments across Europe. She is an experience operator turned investor who is particularly interested in businesses that challenge taboos. Prior to Speedinvest, Andrea was the Chief Revenue Officer at Elvie. She holds a degree in Physics from Oxford and an MBA from Harvard Business School.

Andrea Zitna

Principal
Speedinvest

Andrea Zitna

Principal
Speedinvest

Andrea Zitna is the Principal at Speedinvest, focusing on early-stage health investments across Europe. She is an experience operator turned investor who is particularly interested in businesses that challenge taboos. Prior to Speedinvest, Andrea was the Chief Revenue Officer at Elvie. She holds a degree in Physics from Oxford and an MBA from Harvard Business School.

 

Anna Butterworth

Founder & Director
Ultra Violet Agency

Anna Butterworth is a FemTech pioneer. She has been at the epicentre of the industry for over six years - before the term was even coined. Starting her career in PR she quickly found her calling in wider creative campaign strategy and moved through cause led organisations that support marginalised communities and promote their voices.

Anna Butterworth

Founder & Director
Ultra Violet Agency

Anna Butterworth

Founder & Director
Ultra Violet Agency

Anna Butterworth is a FemTech pioneer. She has been at the epicentre of the industry for over six years - before the term was even coined. Starting her career in PR she quickly found her calling in wider creative campaign strategy and moved through cause led organisations that support marginalised communities and promote their voices.

Landing at Elvie in 2015 she was the first communications hire and quickly grew the brand across 60+ territories leading the way in FemTech marketing strategy. Since branching out to create the world's first FemTech focused creative agency Ultra Violet, she has worked with global disruptors such as Thinx, Become, Doppel, Wuka, Mooncup, Womanizer, Soho House, The Eve Appeal and more.

 

Deepali Nangia

Co-Founder
Alma Angels

Deepali Nangia is the Co-Founder at Alma Angels. Alma is an angel community in support of female founders that encourages and educates women to angel invest into women-owned businesses. The community is only for angels and those wishing to learn about angel investing. She is a is a seasoned angel investor with over a decade of experience in private equity, investment banking and corporate operational roles.

Deepali Nangia

Co-Founder
Alma Angels

Deepali Nangia

Co-Founder
Alma Angels

Deepali Nangia is the Co-Founder at Alma Angels. Alma is an angel community in support of female founders that encourages and educates women to angel invest into women-owned businesses. The community is only for angels and those wishing to learn about angel investing. She is a is a seasoned angel investor with over a decade of experience in private equity, investment banking and corporate operational roles.

 

Dominnique Karetsos

General Partner, CEO
Amboy Street Ventures, Healthy Pleasure Group,

Dominnique Karetsos is the CEO and Co-Founder at The Healthy Pleasure Group, a company with the goal of building a Sexual Health and Technology Economy for better education, innovation, and investment. Alongside this, Dominnique is also a General Partner at Amboy Street Ventures, the world’s first venture capital fund focused on sexual health and women’s health technology startups.

Dominnique Karetsos

General Partner, CEO
Amboy Street Ventures, Healthy Pleasure Group,

Dominnique Karetsos

General Partner, CEO
Amboy Street Ventures, Healthy Pleasure Group,

Dominnique Karetsos is the CEO and Co-Founder at The Healthy Pleasure Group, a company with the goal of building a Sexual Health and Technology Economy for better education, innovation, and investment. Alongside this, Dominnique is also a General Partner at Amboy Street Ventures, the world’s first venture capital fund focused on sexual health and women’s health technology startups.

 

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore is the Co-Founder and Co-CEO at Peppy. A next-generation solution that’s transforming digital healthcare, working with employers and private medical insurers to give individuals physical, mental and emotional support when they need it most. Mridula has spent her career driving innovations in healthcare to make it more accessible and affordable. Most recently she has led commercial teams in the pharmaceuticals and digital health industries. Prior to that she was an engagement manager at McKinsey & Co.

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore is the Co-Founder and Co-CEO at Peppy. A next-generation solution that’s transforming digital healthcare, working with employers and private medical insurers to give individuals physical, mental and emotional support when they need it most. Mridula has spent her career driving innovations in healthcare to make it more accessible and affordable. Most recently she has led commercial teams in the pharmaceuticals and digital health industries. Prior to that she was an engagement manager at McKinsey & Co. She has a PhD in chemical engineering from MIT and an MBA from the MIT Sloan.

 

Dr Nina Zoric

Associate
McKinsey & Company

Nina Zoric is a McKinsey consultant. She is a former practicing embryologist with scientific background and expertise in genetics and fertility. Nina established her practical knowledge in fertility by working in the fertility field before joining McKinsey. Combined with a thorough understanding of the trends and market landscape, she has a holistic view of the fertility space and patients’ needs.  

Dr Nina Zoric

Associate
McKinsey & Company

Dr Nina Zoric

Associate
McKinsey & Company

Nina Zoric is a McKinsey consultant. She is a former practicing embryologist with scientific background and expertise in genetics and fertility. Nina established her practical knowledge in fertility by working in the fertility field before joining McKinsey. Combined with a thorough understanding of the trends and market landscape, she has a holistic view of the fertility space and patients’ needs.  

 

Dr Ronell Klingman (Berstein)

Founder & Board Member
NOGAFem

Dr Ronell Klingman, a female healthcare professional, is Co-Founder of NOGAFem, a Non-for-profit Women’s Health Innovation organization promoting the inclusion of sex and gender sensitive methodologies into Women’s Healthcare technologies and services.

Dr Ronell Klingman (Berstein)

Founder & Board Member
NOGAFem

Dr Ronell Klingman (Berstein)

Founder & Board Member
NOGAFem

Dr Ronell Klingman, a female healthcare professional, is Co-Founder of NOGAFem, a Non-for-profit Women’s Health Innovation organization promoting the inclusion of sex and gender sensitive methodologies into Women’s Healthcare technologies and services.

Ronell is also CEO of Integremed cc, a strategic consulting company to international pharmaceutical companies, and LifeSciMed , a consulting company for Biotech companies in Israel. Together with Dr Michal Sela, Founder and COB, NOGAFem has built a 700+ professional community aimed at positively influencing the underserved women’s health ecosystem to create sustainable impact. We promote advocacy through our highly successful “Women’s Health Matters” Summits together with relevant educational platforms and play a central role in key Women’s Health landscape. Ronell is passionate about volunteering her time and expertise to innovators giving them the tools to match high unmet need challenges to appropriate sex- and gender-sensitive innovation. Assisting founders in creating business models that garner investor confidence and funding, will propel these innovations forward, enabling equitable access to highly personalized solutions to combat some of the most challenging health problems that women face. Partnering with key stakeholders in Europe and the US we are driving this initiative forward on a global level, establishing Israel as a key community of practice. I am able to bring my clinical, pharma and biotech experience, and in-depth knowledge of therapeutic areas and technologies, to help build women within this ecosystem.

 

Erica Kantor

Medical Sector Manager
Sagentia

Erica Kantor

Medical Sector Manager
Sagentia

Erica Kantor

Medical Sector Manager
Sagentia
 

Evie Mulberry

Managing Partner
Astia Fund

Evie Mulberry is the Managing Partner at Astia Fund, an early-stage venture fund investing in women-led companies. Evie manages Astia’s direct investment activity through an international LP base made up of family offices and high net worth women and men investing in companies with women leaders. In this role, Evie is responsible for deal flow curation, deal execution and portfolio management for the global group.

Evie Mulberry

Managing Partner
Astia Fund

Evie Mulberry

Managing Partner
Astia Fund

Evie Mulberry is the Managing Partner at Astia Fund, an early-stage venture fund investing in women-led companies. Evie manages Astia’s direct investment activity through an international LP base made up of family offices and high net worth women and men investing in companies with women leaders. In this role, Evie is responsible for deal flow curation, deal execution and portfolio management for the global group.

 

Gila Tolub

Partner
McKinsey & Company

Passionate about healthcare and its role in improving society, Gila advises CEOs and top teams at the leading life sciences companies on growth strategy, sustainability, Health Equity and organizational transformation. Gila also leads McKinsey's work with Healthcare Innovators in Israel supporting VC funds and CEOs in bringing healthcare innovation to market more quickly.

Gila Tolub

Partner
McKinsey & Company

Gila Tolub

Partner
McKinsey & Company

Passionate about healthcare and its role in improving society, Gila advises CEOs and top teams at the leading life sciences companies on growth strategy, sustainability, Health Equity and organizational transformation. Gila also leads McKinsey's work with Healthcare Innovators in Israel supporting VC funds and CEOs in bringing healthcare innovation to market more quickly.

 

Hana Besbes

Investment Manager
Heal Capital

Hana is Investment Manager with Heal Capital, a European VC with a volume of EUR 100m, investing in technology-enabled healthcare champions actively driving healthcare innovation from Seed and Series A stage. At Heal, Hana is driving investments in the areas of Mental Health, FemTech, Elderly Care, and Chronic Diseases. Hana has been an active Angel Investor, invested in 30+ startups, and is an advocate of female founders in tech.

Hana Besbes

Investment Manager
Heal Capital

Hana Besbes

Investment Manager
Heal Capital

Hana is Investment Manager with Heal Capital, a European VC with a volume of EUR 100m, investing in technology-enabled healthcare champions actively driving healthcare innovation from Seed and Series A stage. At Heal, Hana is driving investments in the areas of Mental Health, FemTech, Elderly Care, and Chronic Diseases. Hana has been an active Angel Investor, invested in 30+ startups, and is an advocate of female founders in tech. Hana is a former top-tier strategy consultant with BCG and Roland Berger with > 6 years across Europe and MENA in digital transformation / open innovation and building new industries from scratch. Hana has a technical background as Dipl.-Ing. Electrical Engineering, MSc Telecommunications.

 

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)
 

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant
 

Karina Vazirova

Co-Founder
Femtech Lab

Karina is the co-founder of FemTech Lab, a global platform for startups in women's health and wellness. Prior to FemTech Lab, Karina founded KV LABS, a product development agency focusing on UX Design, AI & Robotic Automation, led high-growth product teams, and launched digital products in the US, Australia, UK and Europe. Karina is also an International Chess Master. 

Karina Vazirova

Co-Founder
Femtech Lab

Karina Vazirova

Co-Founder
Femtech Lab

Karina is the co-founder of FemTech Lab, a global platform for startups in women's health and wellness. Prior to FemTech Lab, Karina founded KV LABS, a product development agency focusing on UX Design, AI & Robotic Automation, led high-growth product teams, and launched digital products in the US, Australia, UK and Europe. Karina is also an International Chess Master. 

 

Kathrin Folkendt

Founder & CEO, Co-Founder
Femtech Insider, Perla Health

Kathrin Folkendt is the Founder & CEO at Femtech Insider, the number 1 source for all things femtech. The newsletter briefs people on deals, company and startup launches, as well as femtech and Healthtech industry insights. Alongside this, Kathrin is also the Co-Founder of PERLA Health, an evidence-based integrative approach towards changing the way that PCOS education and care are delivered.

Kathrin Folkendt

Founder & CEO, Co-Founder
Femtech Insider, Perla Health

Kathrin Folkendt

Founder & CEO, Co-Founder
Femtech Insider, Perla Health

Kathrin Folkendt is the Founder & CEO at Femtech Insider, the number 1 source for all things femtech. The newsletter briefs people on deals, company and startup launches, as well as femtech and Healthtech industry insights. Alongside this, Kathrin is also the Co-Founder of PERLA Health, an evidence-based integrative approach towards changing the way that PCOS education and care are delivered.

 

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.  Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.

 

Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.

 

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

Keren Leshem, MBA

CEO
OCON Healthcare

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

 

Lea von Bidder

Founder
AVA Women

Lea von Bidder is the CEO and Co-Founder of Ava Women, which leverages big data and artificial intelligence in women’s health. he company's initial product consists of a sophisticated sensor bracelet, an app and a powerful backend with self-learning algorithms for interpretation of hormonal changes, accurate ovulation tracking and screening of women's health issues.

Lea von Bidder

Founder
AVA Women

Lea von Bidder

Founder
AVA Women

Lea von Bidder is the CEO and Co-Founder of Ava Women, which leverages big data and artificial intelligence in women’s health. he company's initial product consists of a sophisticated sensor bracelet, an app and a powerful backend with self-learning algorithms for interpretation of hormonal changes, accurate ovulation tracking and screening of women's health issues.

 

Leon-Ariel Boston

CEO
MobileODT

Consummate CEO and entrepreneurial business leader with consistent track-record of success in the start-up, growth and leadership of high-performance MedTech companies.

In the last years, Leon has focused on women's health, creating new innovative products leveraging the latest digital technologies and artificial intelligence .

He is a regular contributor at different FemTech forums worldwide.

Leon-Ariel Boston

CEO
MobileODT

Leon-Ariel Boston

CEO
MobileODT

Consummate CEO and entrepreneurial business leader with consistent track-record of success in the start-up, growth and leadership of high-performance MedTech companies.

In the last years, Leon has focused on women's health, creating new innovative products leveraging the latest digital technologies and artificial intelligence .

He is a regular contributor at different FemTech forums worldwide.

As a CEO of MobileODT, Leon has been transforming the company into a fully encompassing digital health solution, built on the foundations of AI for cervical cancer screening. With further applications in women’s wellness and fertility under development, MobileODT is evolving as a leading Femtech company transforming lives and changing outcomes for women world-wide.

 

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus is one of Europe’s emerging managers: He is a founder and managing partner at Calm/Storm, an early-stage venture capital fund focused on digital-health and wellbeing. Before founding Calm/Storm in 2020, he was a startup operator, a CFO and a general partner of an early-stage fund (Speedinvest) – a combination not often found in venture capital.

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus is one of Europe’s emerging managers: He is a founder and managing partner at Calm/Storm, an early-stage venture capital fund focused on digital-health and wellbeing. Before founding Calm/Storm in 2020, he was a startup operator, a CFO and a general partner of an early-stage fund (Speedinvest) – a combination not often found in venture capital.

Lucanus is passionate about helping others – especially founders – and will assist in every aspect of building your company. Investors and founders trust him, his hands-on approach and his knowledge around numbers. With more than 35 investments, he and the Calm/Storm team have demonstrated the ability to find and pick those rare cases where entrepreneurs are able to build both outstanding products and big businesses. Lucanus also has a real passion for digital solutions that improve our lives, and has most likely hit the limit of the number of apps "installable" on a phone.

In his free time, you’ll find him spending time with his wife and three children in the most liveable city in the world, Vienna, Austria, or sometimes racing sailing boats in his home turf, Lake Attersee in beautiful Salzkammergut – or as he calls it, “The Sound Of Music Land”.

 

Lucy Perez, PhD

Senior Partner
McKinsey & Company

Lucy Perez, PhD

Senior Partner
McKinsey & Company

Lucy Perez, PhD

Senior Partner
McKinsey & Company
 

Lynae Brayboy

Chief Medical Officer
Clue

Lynae is the Chief Medical Officer at Clue, the company founded by Ida Tin who coined the term ‘femtech’. Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it and was launched helloclue.com in February 2018 to help close the knowledge gap about the menstrual cycle—with information that’s accessible, serious, scientific, and empathetic.

Lynae Brayboy

Chief Medical Officer
Clue

Lynae Brayboy

Chief Medical Officer
Clue

Lynae is the Chief Medical Officer at Clue, the company founded by Ida Tin who coined the term ‘femtech’. Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it and was launched helloclue.com in February 2018 to help close the knowledge gap about the menstrual cycle—with information that’s accessible, serious, scientific, and empathetic.

 

Melis Guvensoy

Founder & Executive Director
Bold Innovation

Melis is a strategic consultant, entrepreneur and a business developer in life sciences. After finishing her bachelor in biochemistry at University of Leicester and her masters in cancer therapeutics at Queen Mary University of London, she has gathered experience in supply chain, sales and business analysis in the UK and Cyprus to understand the world of entrepreneurship and innovation from different industry perspectives. Later, she took on a business development role at Whale Bay & Co (Deloitte spin-off), a life sciences and health consultancy company in the Netherlands.

Melis Guvensoy

Founder & Executive Director
Bold Innovation

Melis Guvensoy

Founder & Executive Director
Bold Innovation

Melis is a strategic consultant, entrepreneur and a business developer in life sciences. After finishing her bachelor in biochemistry at University of Leicester and her masters in cancer therapeutics at Queen Mary University of London, she has gathered experience in supply chain, sales and business analysis in the UK and Cyprus to understand the world of entrepreneurship and innovation from different industry perspectives. Later, she took on a business development role at Whale Bay & Co (Deloitte spin-off), a life sciences and health consultancy company in the Netherlands. Afterwards, she joined a contract research organisation called OcellO BV, as a business manager, that does 3D in vitro compound screening in a physiologically relevant patient disease environment using organoids. She is also a board member in the European Institute of Innovation and Technology (EIT) Women community, and an active member in Cyprus Women's Health Research Society. In 2021, Melis founded Bold Innovates. In her role at Bold Innovates, next to managing the company, she leads the innovation development and growth strategy of client projects.

 

 

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is launching a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is launching a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

 

Shardi Nahavandi

CEO
TUUNE

Shardi Nahavandi is the Co-Founder and CEO of TUUNE, a startup focusing on personalized birth control. She was inspired to start the company after being misdiagnosed with bowel cancer, eventually focusing on her own research on hormone imbalances.

Shardi Nahavandi

CEO
TUUNE

Shardi Nahavandi

CEO
TUUNE

Shardi Nahavandi is the Co-Founder and CEO of TUUNE, a startup focusing on personalized birth control. She was inspired to start the company after being misdiagnosed with bowel cancer, eventually focusing on her own research on hormone imbalances.

 

Dr. Stephen Gerrard Ph.D.

Independent Expert Advisor Contraception R&D
Contraception R&D

Dr. Stephen Gerrard Ph.D.

Independent Expert Advisor Contraception R&D
Contraception R&D

Dr. Stephen Gerrard Ph.D.

Independent Expert Advisor Contraception R&D
Contraception R&D
 

Susan Nicholson

SVP Women's Health
Johnson & Johnson

Susan Nicholson

SVP Women's Health
Johnson & Johnson

Susan Nicholson

SVP Women's Health
Johnson & Johnson
 

Therese Maria Liechtenstein

Principal
M Ventures

Therese Liechtenstein, PhD, is a Principal in the Biotechnology team of M Ventures. Therese joined M Ventures in 2018. She was instrumental in the creation and financing of multiple companies of M Ventures portfolio, including FoRx Therapeutics and Anavo Therapeutics. Thera actively leads investments and represents M Ventures on the board of multiple portfolio companies. Previously Therese managed strategic projects for the Healthcare business of Merck KGaA in Darmstadt, Germany.

Therese Maria Liechtenstein

Principal
M Ventures

Therese Maria Liechtenstein

Principal
M Ventures

Therese Liechtenstein, PhD, is a Principal in the Biotechnology team of M Ventures. Therese joined M Ventures in 2018. She was instrumental in the creation and financing of multiple companies of M Ventures portfolio, including FoRx Therapeutics and Anavo Therapeutics. Thera actively leads investments and represents M Ventures on the board of multiple portfolio companies. Previously Therese managed strategic projects for the Healthcare business of Merck KGaA in Darmstadt, Germany. Prior to Merck KGaA, Darmstadt, Germany, Therese was a client relationship manager in the field of wealth preservation, at Industrie- & Finanzkontor Ets. Therese comes from an academic background receiving her PhD in Immuno-Oncology from University College London, an MSc in Biomedical Sciences from the University of Amsterdam, and a BA in Biology and Business studies from New York University.

 

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical

Thomas Crouzier

MD, CSO & Co-Founder
Cirqle Biomedical
 

Valerie Palmieri

CEO
Aspira Women's Health

Valerie Palmieri

CEO
Aspira Women's Health

Valerie Palmieri

CEO
Aspira Women's Health
 

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009.

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009. Wendy chairs the Board at Be Girl, a mission-driven design company addressing menstruation, is on the Executive Board of Women Moving Millions and sits on the advisory boards of both Saral Designs and The Center for Intimacy Justice.

 

Allison Watkins-Conti

Founder/CEO
Watkins-Conti

Allison Watkins-Conti

Founder/CEO
Watkins-Conti

Allison Watkins-Conti

Founder/CEO
Watkins-Conti

DOWNLOAD AGENDA

Be the first to view our 2022 Women's Health Innovation Summit Europe agenda!

Sessions include:

  • Innovation and Investment in Europe: Driving Growth in Women’s Health

  • Hormonal Health: The Next Frontier

  • Engaging Employers to Increase Women’s Access to Healthcare

Our agenda provides all the information you need to book your place at Women's Health Innovation Summit EU, access your copy today!

Download the WHIS EU Agenda

REGISTRATION

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Saturday, January 15, 2022 to Friday, February 11, 2022
Emerging
€599
Super Early Bird (Register before 11th February and save €300)
Saturday, January 15, 2022 to Friday, February 11, 2022
Industry
€1,299
Super Early Bird (Register before 11th February and save €400)
Saturday, January 15, 2022 to Friday, February 11, 2022
Service Providers
€1,799
Super Early Bird (Register before 11th February and save €400)
Preparing registration...

Become a Partner

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920, email Duncan Henderson at [email protected] or downloading our agenda and clicking the "Interested in Sponsorship" box below.

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.